Sequential Treatment With CD20/CD22/CD10-CART After CD19-CART Treatment Base on MRD in Relapsed/Refractory B-ALL
Clinical trial NCT03407859 · UNKNOWN
Trial details
- NCT number
- NCT03407859
- Sponsor
- Zhujiang Hospital
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-18
- Primary completion
- 2024-12-31
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.